These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1944163)

  • 41. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of T antigen expression in patients with gastric carcinoma.
    Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
    Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second cancer following cancer of the digestive system in Connecticut, 1935-82.
    Hoar SK; Wilson J; Blot WJ; McLaughlin JK; Winn DM; Kantor AF
    Natl Cancer Inst Monogr; 1985 Dec; 68():49-82. PubMed ID: 4088313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
    Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
    Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].
    Tabuchi Y; Deguchi H; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1181-91. PubMed ID: 3185486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
    Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
    Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mortality after digestive cancer surgery].
    Isono K; Asano T
    Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):529-38. PubMed ID: 7565574
    [No Abstract]   [Full Text] [Related]  

  • 49. [Expression and clinical significance of type-1 blood group antigens (Lea, Leb, CA19-9) in colorectal cancer--comparison with CEA].
    Kiriyama K; Watanabe T; Sakamoto J; Ito K; Akiyama S; Yamauchi M; Takagi H
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):320-30. PubMed ID: 1675759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [2D3 series, MSW 113 and other monoclonal antibodies directed to type 1 chain carbohydrate antigens].
    Kannagi R; Takada A; Shigeta K; Itai S; Hashimoto K
    Nihon Rinsho; 1990 Feb; 48 Suppl():992-8. PubMed ID: 2355641
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma.
    Dohi T; Abe K; Ohshiba S
    Gastroenterol Jpn; 1989 Jun; 24(3):239-45. PubMed ID: 2663606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of three sialylated tumor-associated antigens in malignant serous effusions.
    Kadota J
    Tohoku J Exp Med; 1990 Jul; 161(3):171-83. PubMed ID: 2247889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination and significance of a new carbohydrate antigen CA19-9 in digestive system cancers.
    Arakawa Y; Ariga H; Kano M; Matsuo Y; Honda T; Morita K
    Jpn J Med; 1985 May; 24(2):121-30. PubMed ID: 3860677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical expression of blood group substances and related carbohydrate antigens in breast carcinoma.
    Nakagoe T; Fukushima K; Hirota M; Kusano H; Kawahara K; Ayabe H; Tomita M; Kamihira S
    Jpn J Cancer Res; 1991 May; 82(5):559-68. PubMed ID: 1905702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [CA19-9, CA242].
    Odagiri E
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():685-7. PubMed ID: 20960851
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract.
    Ohshio G; Yoshioka H; Manabe T; Sakahara H; Yamabe H; Imamura M; Inoue M; Tanaka N; Nakada H; Yamashina I
    J Cancer Res Clin Oncol; 1994; 120(6):325-30. PubMed ID: 8138557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer.
    Narita T; Funahashi H; Satoh Y; Watanabe T; Sakamoto J; Takagi H
    Cancer; 1993 May; 71(10):3044-53. PubMed ID: 8490832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The diversity expression of p62 in digestive system cancers.
    Su Y; Qian H; Zhang J; Wang S; Shi P; Peng X
    Clin Immunol; 2005 Aug; 116(2):118-23. PubMed ID: 15886058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.
    Satomura Y; Sawabu N; Takemori Y; Ohta H; Watanabe H; Okai T; Watanabe K; Matsuno H; Konishi F
    Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality trends of malignant tumours of digestive organs in Belgrade, Yugoslavia, 1975-1997.
    Adanja B; Gledovic Z; Pekmezovic T; Vlajinac H; Jarebinski M; Zivaljevic V; Pavlovic M
    Dig Liver Dis; 2000; 32(5):386-91. PubMed ID: 11030183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.